App is temporarily unavailable
OEGARI Dauermedikation
Description
Diese Application gibt Ihnen eine schnelle Information über das Management der Dauermedikation in der perioperativen Phase.
Anhand der ICONS ist schnell ersichtlich ob die Medikamentengruppe präopertiv pausiert werden sollte oder am Op Tag weiterverordnet werden sollte.
Pause Icon = Medikation Pausieren
Tabletten Icon = Medikation am OP Tag verordnen
ARGE Präoperatives und Tagesklinisches Patientenmanagement
Hide
Show More...
Anhand der ICONS ist schnell ersichtlich ob die Medikamentengruppe präopertiv pausiert werden sollte oder am Op Tag weiterverordnet werden sollte.
Pause Icon = Medikation Pausieren
Tabletten Icon = Medikation am OP Tag verordnen
ARGE Präoperatives und Tagesklinisches Patientenmanagement
OEGARI Dauermedikation FAQ
-
Is OEGARI Dauermedikation free?
Yes, OEGARI Dauermedikation is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is OEGARI Dauermedikation legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does OEGARI Dauermedikation cost?
OEGARI Dauermedikation is free.
-
What is OEGARI Dauermedikation revenue?
To get estimated revenue of OEGARI Dauermedikation app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Saudi Arabia yet.
Ratings History
OEGARI Dauermedikation Reviews
No Reviews in Saudi Arabia
App doesn't have any reviews in Saudi Arabia yet.
OEGARI Dauermedikation Installs
Last 30 days
OEGARI Dauermedikation Revenue
Last 30 daysOEGARI Dauermedikation Revenue and Downloads
Gain valuable insights into OEGARI Dauermedikation performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 1.0 (5 years ago )
- Released on
- Nov 11, 2019 (5 years ago )
- Last Updated
- 10 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.